Skip to main content

Table 1 Selected characteristics of the EPICAP study population (N = 1693)

From: Occupation and prostate Cancer risk: results from the epidemiological study of prostate cancer (EPICAP)

Characteristics Cases
n = 818 (%)
Controls
n = 875 (%)
p-value*
Gleason score at diagnosis  
  ≤ 7 623 (77.4)
  ≥ 7†† 182 (22.6)
Age 0.150
  < 55 years 48 (5.9) 59 (6.7)
 55–59 years 99 (12.1) 99 (11.3)
 60–64 years 216 (26.4) 200 (22.9)
 65–69 years 274 (33.5) 283 (32.3)
  ≥ 70 years 181 (22.1) 234 (26.8)
Ethnic origin 0.402
 Caucasian, 794 (97.1) 855 (97.7)
 Others 24 (2.9) 20 (2.3)
First-degree family history of prostate cancer < 0.001
 no 548 (75.2) 722 (90.5)
 yes 181 (24.8) 76 (9.5)
Educational level 0.503
 none 70 (8.5) 71 (8.1)
 primary school 376 (46.0) 434 (49.7)
 high school 112 (13.7) 109 (12.5)
 university 260 (31.8) 260 (29.7)
Marital status 0.193
 married/domestic partnership 674 (82.4) 748 (85.5)
 divorced/separated/single 115 (14.1) 98 (11.2)
 widowed 29 (3.5) 29 (3.3)
Smoking status 0.362
 non-smokers 240 (29.4) 246 (28.1)
 former smokers 454 (55.6) 475 (54.3)
 current smokers 123 (15.0) 154 (17.6)
Regular alcohol drinking 0.576
 no 72 (8.8) 84 (9.6)
 yes 744 (91.2) 790 (90.4)
Intensity of physical activity 0.123
  < 1 h/week 191 (23.5) 177 (20.3)
 lifetime MET between 0.10–6.23 153 (18.8) 172 (19.8)
 lifetime MET between 6.25–13.01 133 (16.4) 172 (19.8)
 lifetime MET between 13.07–24.11 149 (18.3) 175 (20.1)
 lifetime MET between 24.15–351.40 187 (23.0) 174 (20.0)
Waist circumference (in centimetres) 0.082
  ≤ 94 208 (25.8) 253 (29.6)
  > 94 599 (74.2) 602 (70.4)
Body-mass index 2 years before diagnosis or interview, in kg/m2 0.862
  < 25 296 (36.7) 314 (36.5)
 25–29 377 (46.7) 394 (45.9)
  ≥ 30 134 (16.6) 151 (17.6)
Night shift work 0.522
 never 532 (65.0) 556 (63.5)
 ever 286 (35.0) 319 (36.5)
Last screening for prostate cancer before interview, in years  
  ≤ 2 606 (75.2)
  > 2 66 (8.2)
Never screened 134 (16.6)
  1. Abbreviations. *p-value: Chi-2 test;  ≤ 7(3 + 4): low aggressive cancer; †† ≥ 7 (4 + 3): high aggressive cancer; MET Metabolic Equivalent of Task